Monoclonal antibody therapy for COVID-19 safe, effective for transplant patients
Alcohol companies earned billions from underage drinking in 2016
10 June 2021New research a ‘step change’ for diabetes patients
10 June 2021Monoclonal antibody therapy for COVID-19 safe, effective for transplant patients
Treating transplant patients with mild to moderate cases of COVID-19 with monoclonal antibodies is safe and helps prevent serious illness, according to a Mayo Clinic study recently published in Open Forum Infectious Diseases. These results are especially important because transplant patients who are infected with COVID-19 have a higher risk of severe illness and death.
